CYCLERION THERAPEUTICS INC CYCN 深 滬
等待開盤 10-28 09:30:00 美东时间
2.10
-0.020
-0.94%
華盛通- 最 高2.206
- 今 開2.11
- 成交量 1.77万股
- 最 低 2.06
- 昨 收 2.12
- 總市值 700.85万
- 52周最高 9.4699
- 市盈率 靜 --
- 換手率 0.53%
- 52周最低 1.27
- 委 比 20.81%
- 總股本 333.74万
- 歷史最高 296.60
- 量 比 0.46
- 振 幅 6.89%
- 歷史最低 1.27
- 每 手 1
- 風險率 0.58%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cycurion, Inc. Announces Reverse Stock Split Effective October 27, 2025, for Purpose of Remaining Nasdaq Compliant
Cycurion Inc. (NASDAQ: CYCU), a cybersecurity solutions provider, announced that its previously announced 1-for-30 reverse stock split will take effect on October 27, 2025, reducing the number of outstanding shares from approximately 86.5 million to 2.88 million. Stockholders will not receive fractional shares; instead, they will be paid in cash for any fractional shares based on the closing price prior to the effective date. Proportionate adjust...
10-23 15:00
Cycurion, Inc. Announces Nasdaq Delisting Determination Letter
Cycurion, Inc. (NASDAQ: CYCU) received a delisting determination letter from Nasdaq on October 14, 2025, after its common stock closed below $1.00 for 30 consecutive days. The company failed to regain compliance with Nasdaq's Bid Price Rule by the October 6, 2025 deadline. Cycurion submitted an appeal request to a Hearings Panel on October 20, 2025, which could delay the delisting process. The company also implemented a 30:1 reverse stock split e...
10-20 20:30
Stocks to Watch: Aytu BioPharma, Cohu, Cyclerion
Unity Software(U.US) reported fourth-quarter financial results after the market...
09-24 07:17
Cyclerion Therapeutics Relaunches with Neuropsychiatric Focus
Cyclerion Therapeutics ( ($CYCN) ) has issued an update. On September 19, 2025,...
09-24 05:13
快讯 | Cyclerion Therapeutics - 根据许可协议，Mit有资格获得高达440万美元的里程碑付款 - SEC文件
Cyclerion Therapeutics - Under License Agreement, Mit Eligible for up to $4.4 M...
09-24 04:19
Cyclerion Announces License Agreement With MIT To Relaunch Advancing Phase 2–Ready Treatment For Resistant Depression
– Cyclerion Relaunches, Advancing a Phase 2–Ready Program for Millions Living with Treatment-Resistant Depression Through MIT License Agreement –– Webcast to be held September 24, 2025 at 10:30 a.m.
09-24 04:04
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
Cyclerion Therapeutics与麻省理工学院达成协议，专注于治疗抵抗性抑郁症的新疗法，II期临床试验计划于2026年启动。2025年9月24日上午10:30，网络直播将讨论这一进展及其未来计划。
09-23 20:01
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers iSpecimen (NASDAQ:ISPC) shares increased by 80.7% to $1.35 during Tues...
09-10 01:06
Cycurion Inc. Regains Compliance with Nasdaq Listing Requirements
Cycurion Inc. (NASDAQ: CYCU) has regained compliance with Nasdaq Listing Rules following a notification on August 19, 2025, confirming the company meets the $10 million stockholders' equity requirement. Additionally, on August 20, 2025, the company was informed that it has satisfied the $5 million market value of publicly held shares rule. This resolves the previous notice of non-compliance regarding the market value of listed securities rule. Cy...
08-21 20:15
IQST - IQSTEL and Cycurion (CYCU) Sign MOU for Equity Exchange and Alliance to Build a Next-Gen AI-Driven Powerhouse with Half of the Stock to be Distributed as a Dividend to Shareholders
IQSTEL Inc. and Cycurion Inc. have signed an MOU to become mutual equity partners via a $1 million stock exchange, with 50% of shares distributed as dividends to enhance shareholder value. The collaboration combines IQSTEL's global telecom presence with Cycurion's U.S. market strength in government and institutional sectors. Together, they aim to develop advanced AI-driven cybersecurity solutions, boost innovation, and expand cross-selling opport...
08-07 12:45
